Recent News

The latest news from the governments, medical industry and top online sources.

Meeting highlights from the Pharmacovigilance Risk Assessmen…

PRAC elects new chair The July 2024 meeting of EMA’s safety committee (PRAC) was the last plenary meeting chaired by Sabine Straus, who retires as Chair after serving for two three-year mandates. EMA would like to thank Sabine Straus for her leadership and vision that were essential in steering the PRAC during the past six years. Her expertise […]

Coloplast launches digital leakage notification system Heylo…

More than 176,000 people in the UK are living with a stoma, according to NHS data Coloplast has announced the launch of its world-first digital leakage notification system, Heylo, to benefit patients living with a stoma. The new system is now available through the NHS to help alleviate the physical and mental burden of leakage […]

Meeting highlights from the Committee for Veterinary Medicin…

The Committee adopted by consensus a positive opinion for a marketing authorisation for DIVENCE IBR Marker Live from Laboratorios Hipra, S.A., a new vaccine intended for the active immunisation of cattle from 10 weeks of age to reduce virus shedding, hyperthermia and clinical signs caused by bovine herpesvirus type 1 (BoHV-1). The Committee adopted by […]

Leuko device to remotely monitor cancer patients during chem…

Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020 Leuko, founded by researchers at the Massachusetts Institute of Technology (MIT), has developed an at-home white blood cell monitor to help doctors non-invasively monitor cancer patients’ health during chemotherapy. The PointCheck device provides an easy-to-use way of recording immune health […]

EU recommendations for 2024/2025 seasonal flu vaccine compos…

EMA has issued recommendations for the influenza virus strains1,2 that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2024. Every year, EMA issues EU recommendations for the composition of seasonal influenza vaccines on the basis of observations by the World Health Organization (WHO) which are informed by regular monitoring […]

King’s Doctoral Training Centre to investigate MS symptom ma…

The lifelong autoimmune disease affects more than 150,000 people living in the UK A new King’s Doctoral Training Centre at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College London (KCL) has been launched to investigate symptom management for multiple sclerosis (MS) without using drugs. Funded by the MS Society, the new training […]

Meeting highlights from the Committee for Medicinal Products…

Eight new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting. The CHMP recommended granting a marketing authorisation for Altuvoct* (efanesoctocog alfa), for the treatment and prophylaxis of bleeding in patients with haemophilia A, a rare inherited bleeding disorder caused by lack of factor VIII. The committee […]

Cambridge researchers develop robotic nerve devices for neur…

Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide Researchers at the University of Cambridge have developed small, flexible devices, combining electronics and soft robotics, to help treat a range of neurological conditions, including epilepsy and chronic pain. Published in Nature Materials, the nerve cuff implant has the ability to […]

Meeting highlights from the Committee for Veterinary Medicin…

CVMP opinions on veterinary medicinal products  The Committee adopted by consensus a positive opinion for a marketing authorisation application for a vaccine that is effective against the currently circulating strains of highly pathogenic avian influenza (HPAI). Innovax-ND-H5 (turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of avian […]

Francis Crick researchers reveal pathways linking intestinal…

Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis The study, published in Nature Immunology, could help identify new ways to treat inflammatory bowel disease (IBD). Collectively known as IBD, Crohn’s disease and ulcerative colitis are incurable conditions that involve excessive inflammation in the gut and affect over 500,000 people […]